Integrating medication for opioid use disorder in African American communities.
Official title: BETTER TOGETHER: INTEGRATING MOUD IN AFRICAN AMERICAN COMMUNITY SETTINGS. SEPTEMBER 15, 2023 TO JANUARY 31, 2026. N01DA-22-2253. TASK ORDER 75N95023F00004 (TO8).
Funded at The Emmes Company, LLC · NIH-10938767 · Data updated 2026-11-12
This study is working to improve support for people in the African American community who are dealing with opioid misuse by bringing effective medication and resources right into their neighborhoods, making sure the help is relevant and easy to access.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 15, 2023 |
| Project end | January 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $999,995 |
| NIH project number | 75N95022D00017-0-759502300004-1 |
| Project ID | NIH-10938767 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are African American individuals who are experiencing opioid misuse or dependence.
✕Less likely to help
Patients who do not identify as African American or those who are not struggling with opioid misuse may not benefit from this research.
What this research studies
This research focuses on enhancing the treatment of opioid misuse and addiction specifically within African American community settings. It aims to integrate medication for opioid use disorder (MOUD) into these communities to provide effective support and resources for individuals struggling with opioid dependence. The approach involves collaboration with local organizations to ensure culturally relevant and accessible treatment options. By addressing the unique challenges faced by these communities, the research seeks to develop sustainable strategies for combating the opioid crisis.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective treatment for opioid addiction in African American communities.
How similar studies have gone: Previous research has shown success in integrating community-based approaches to treat opioid addiction, indicating that this method could be effective.
Where this research is happening
-
The Emmes Company, LLC
Rockville, United States Active
Researchers
- Principal investigator: Mccormack, Jennifer — The Emmes Company, LLC
- Study coordinator: Mccormack, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.